Circulating myocardial microRNAs from infarcted hearts are carried in exosomes and mobilise bone marrow progenitor cells

Nature Communications

Volumn 10, Issue 1, 2019, Pages

  Cheng, Min ^a   Yang, Junjie ^b   Zhao, Xiaoqi ^a   Zhang, Eric ^b   Zeng, Qiutang ^a   Yu, Yang ^b   Yang, Liu ^a,b   Wu, Bangwei ^c   Yi, Guiwen ^a   Mao, Xiaobo ^a   Huang, Kai ^a   Dong, Nianguo ^a   Xie, Min ^d   Limdi, Nita A ^e   Prabhu, Sumanth D ^d   Zhang, Jianyi ^b   Qin, Gangjian ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b and Radiation Oncology   (United States)

^c FUDAN UNIVERSITY   (China)

^d University of Alabama at Birmingham and Birmingham Veterans Affairs Medical Center   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CIRCULATING MICRORNA; MELOXICAM; MICRORNA 1; MICRORNA 133; MICRORNA 208; MICRORNA 499; UNCLASSIFIED DRUG; CXCR4 PROTEIN, MOUSE; MICRORNA;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW DERIVED MONONUCLEAR CELL; BONE MARROW PROGENITOR CELL; CASE REPORT; CLINICAL ARTICLE; CONTROLLED STUDY; EXOSOME; FLOW CYTOMETRY; HEART MUSCLE ISCHEMIA; HUMAN; MALE; MOUSE; NONHUMAN; POSTOPERATIVE PAIN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; BLOOD; C57BL MOUSE; CARDIAC MUSCLE; DOWN REGULATION; FEMALE; HEART INFARCTION; HEMATOPOIETIC STEM CELL; METABOLISM; MIDDLE AGED; PATHOLOGY; STEM CELL MOBILIZATION;

AGED; ANIMALS; DOWN-REGULATION; EXOSOMES; FEMALE; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; RECEPTORS, CXCR4;

EID: 85062278194     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-019-08895-7     Document Type: Article

References (39)

1. Losordo, D. W. & Vaughan, D. E. Going mobile: enhanced recovery from myocardial infarction via stem cell mobilization and homing for tissue repair. J. Am. Coll. Cardiol. 63, 2873–2874 (2014).
2. Afzal, M. R. et al. Adult bone marrow cell therapy for ischemic heart disease: evidence and insights from randomized controlled trials. Circ. Res. 117, 558–575 (2015).
3. Jonas, S. & Izaurralde, E. Towards a molecular understanding of microRNA-mediated gene silencing. Nat. Rev. Genet. 16, 421–443 (2015).
4. Corsten, M. F. et al. Circulating microRNA-208b and microRNA-499 reflect myocardial damage in cardiovascular disease. Circ. Cardiovasc. Genet. 3, 499–506 (2010).
5. Kuwabara, Y. et al. Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. Circ. Cardiovasc. Genet. 4, 446–454 (2011).
6. Wang, G. K. et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur. Heart J. 31, 659–666 (2010).
7. Devaux, Y. et al. Use of circulating microRNAs to diagnose acute myocardial infarction. Clin. Chem. 58, 559–567 (2012).
8. Sahoo, S. & Losordo, D. W. Exosomes and cardiac repair after myocardial infarction. Circ. Res. 114, 333–344 (2014).
9. Cheng, M. et al. CXCR4-mediated bone marrow progenitor cell maintenance and mobilization are modulated by c-kit activity. Circ. Res. 107, 1083–1093 (2010).
10. Jujo, K. et al. CXC-chemokine receptor 4 antagonist AMD3100 promotes cardiac functional recovery after ischemia/reperfusion injury via endothelial nitric oxide synthase-dependent mechanism. Circulation 127, 63–73 (2013).
11. Sahoo, S. et al. Exosomes from human CD34(+) stem cells mediate their proangiogenic paracrine activity. Circ. Res. 109, 724–728 (2011).
12. Khan, M. et al. Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction. Circ. Res. 117, 52–64 (2015).
13. Cheng, Y. et al. A translational study of urine miRNAs in acute myocardial infarction. J. Mol. Cell. Cardiol. 53, 668–676 (2012).
14. Tabet, F. et al. HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells. Nat. Commun. 5, 3292 (2014).
15. Vickers, K. C., Palmisano, B. T., Shoucri, B. M., Shamburek, R. D. & Remaley, A. T. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat. Cell Biol. 13, 423–433 (2011).
16. Arroyo, J. D. et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc. Natl Acad. Sci. USA 108, 5003–5008 (2011).
17. Hessvik, N. P. & Llorente, A. Current knowledge on exosome biogenesis and release. Cell. Mol. Life Sci. 75, 193–208 (2018).
18. Villarroya-Beltri, C. et al. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat. Commun. 4, 2980 (2013).
19. Koppers-Lalic, D. et al. Nontemplated nucleotide additions distinguish the small RNA composition in cells from exosomes. Cell Rep. 8, 1649–1658 (2014).
20. Squadrito, M. L. et al. Endogenous RNAs modulate microRNA sorting to exosomes and transfer to acceptor cells. Cell Rep. 8, 1432–1446 (2014).
21. Zhang, J. et al. Exosome and exosomal microRNA: trafficking, sorting, and function. Genom. Proteom. Bioinf. 10.1016/j.gpb.2015.02.001 (2015).
22. Cheng, M. et al. A critical role of Src family kinase in SDF-1/CXCR4-mediated bone-marrow progenitor cell recruitment to the ischemic heart. J. Mol. Cell. Cardiol. 81, 49–53 (2015).
23. Leone, V. et al. MiR-1 is a tumor suppressor in thyroid carcinogenesis targeting CCND2, CXCR4, and SDF-1alpha. J. Clin. Endocrinol. Metab. 96, E1388–E1398 (2011).
24. Boon, R. A. & Dimmeler, S. MicroRNAs in myocardial infarction. Nat. Rev. Cardiol. 12, 135–142 (2015).
25. van Mil, A. et al. MicroRNA-1 enhances the angiogenic differentiation of human cardiomyocyte progenitor cells. J. Mol. Med. 91, 1001–1012 (2013).
26. Huang, F. et al. Overexpression of MicroRNA-1 improves the efficacy of mesenchymal stem cell transplantation after myocardial infarction. Cardiology 125, 18–30 (2013).
27. Zhang, L. L. et al. MiR-499 induces cardiac differentiation of rat mesenchymal stem cells through wnt/beta-catenin signaling pathway. Biochem. Biophys. Res. Commun. 420, 875–881 (2012).
28. Jayawardena, T. M. et al. MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ. Res. 110, 1465–1473 (2012).
29. Jayawardena, T. M. et al. MicroRNA induced cardiac reprogramming in vivo: evidence for mature cardiac myocytes and improved cardiac function. Circ. Res. 116, 418–424 (2015).
30. Ong, S. G. et al. Cross talk of combined gene and cell therapy in ischemic heart disease: role of exosomal microRNA transfer. Circulation 130, S60–S69 (2014).
31. Vicencio, J. M. et al. Plasma exosomes protect the myocardium from ischemia-reperfusion injury. J. Am. Coll. Cardiol. 65, 1525–1536 (2015).
32. Tang, Y. L. et al. Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression. Circ. Res. 104, 1209–1216 (2009).
33. Li, P., Kaslan, M., Lee, S. H., Yao, J. & Gao, Z. Progress in exosome isolation techniques. Theranostics 7, 789–804 (2017).
34. Coumans, F. A. W. et al. Methodological guidelines to study extracellular vesicles. Circ. Res. 120, 1632–1648 (2017).
35. Sluijter, J. P. G. et al. Extracellular vesicles in diagnostics and therapy of the ischaemic heart: Position Paper from the Working Group on Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc. Res. 114, 19–34 (2018).
36. Wang, X. et al. Engineered exosomes with ischemic myocardium-targeting peptide for targeted therapy in myocardial infarction. J. Am. Heart Assoc. 7, e008737 (2018).
37. Cheng, M. et al. CXCR4-mediated bone marrow progenitor cell maintenance and mobilization are modulated by c-kit activity. Circ. Res. 107, 1083–1093 (2010).
38. Krutzfeldt, J. et al. Silencing of microRNAs in vivo with ‘antagomirs’. Nature 438, 685–689 (2005).
39. McClure, C. et al. MicroRNA 21 (miR-21) and miR-181b couple with NFI-A to generate myeloid-derived suppressor cells and promote immunosuppression in late sepsis. Infect. Immun. 82, 3816–3825 (2014).